Science and Engineering
Impulse Programme: Turning world‑class science into commercial impact
Applications close soon for Impulse 2026. Round One deadline has now passed (2 February 2026)Round Two deadline: 2 March 2026 Now in its 10th year, the Impulse Programme, delivered through the Maxwell Centre at the University of Cambridge, helps science and tech researchers de...
Astoriom acquires Precision Stability Storage
Acquisition strengthens Astoriom’s stability storage capabilities to meet increasing demand across North America Offers reliable, compliant, and accessible solutions to advance scientific discovery and product developmentRochdale, UK, and North Carolina, US, 27 January 2026: Astoriom, a...
Women at the cutting edge: driving inclusive surgical design
Gender bias in surgical devices impacts women surgeons, compromising both their performance and well-being. Many instruments and protective equipment have historically been designed using data based on male physical characteristics, creating systemic challenges for female practitioners....
Verlingue acquires Cambridge-based Employee Benefits specialist EBCam
Verlingue announces the acquisition of Cambridge-based Employee Benefits and Financial Planning specialist, EBCam, marking an important step in its continued expansion in the UK Employee Benefits market. ...
Regulatory compliance in medical device development: a driver for success
Treating regulatory compliance as a late-stage hurdle creates risk, redesigns, and delays, especially for complex wearable and implantable devices. Bringing regulatory thinking in early turns compliance into a design tool, reducing uncertainty and helping teams move faster with confiden...
Gene therapies for wet AMD: reshaping the blockbuster anti‑VEGF market
This month, VacZine Analytics, a specialist publisher in healthcare commercial analysis, releases a brand-new global forecast focused on new gene therapies for Wet age-related macular degeneration (wet AMD). ...
Introducing PhiZ & Co: Practical patient engagement for growing life science teams
One of the strengths of the Cambridge life sciences community is how openly teams share both challenges and progress. And one key question many founders, researchers, and innovators are facing is: how do you meaningfully involve patients in early research plans or content creation when ...
Secure peace of mind with Public Safety DAS
Why Every Modern Building Needs Public Safety DAS for Emergency Response
ELRIG Announces Drs Stephen Ward and Annarita Miccio as Keynote Speakers for Cell and Gene Therapy 2026
Inaugural event takes place from 9–10 March at Hinxton Hall in Cambridge, UK. Programme spans neurological disorders, sensory diseases, rare conditions, and cancer immunotherapy ...
What AI in healthcare really needs
Co-authored by By Claudio Silvestrin